Virtual Biotech

To be or not to be - that is the most pressing question for biotech companies today. In his recent blog article, David Grainger asks just how much out-sourcing is the right amount?

You can download the blog as a PDF.

To view other similar posts, visit the ATPBlog at: www.atpblog.typepad.com